Position in ABUS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,811,314
+$1,060,951 QoQ
Shares Held
1,419,024
+11.0% QoQ
Ownership
0.717%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 175 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. ABUS ranks #138 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ABUS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,811,314 | 1,419,024 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $5,750,363 | 1,277,859 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $5,948,471 | 1,236,689 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $5,853,932 | 1,289,413 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,968,233 | 1,284,219 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $4,479,764 | 1,283,601 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,351,331 | 1,330,683 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $4,729,500 | 1,228,442 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $3,248,593 | 1,051,325 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $2,726,037 | 1,056,604 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,670,552 | 1,068,221 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,162,704 | 1,065,372 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,399,959 | 1,043,461 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,878,166 | 949,890 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,140,665 | 918,741 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,720,044 | 900,547 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,430,793 | 896,972 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,307,231 | 774,239 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,857,080 | 734,468 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $3,005,161 | 700,504 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,179,050 | 719,159 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $441,900 | 132,703 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $405,420 | 114,203 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $374,606 | 119,683 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $187,071 | 102,787 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||